Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
AERAS-456 in HIV-Negative Adults With and Without Latent Tuberculosis Infection
NCT01865487Phase 2Completed
- Sponsor
- Aeras Global Vaccine Foundation
- Start
- Aug 2013
- Primary completion
- Aug 2015
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 2 trial of AERAS-456 in Tuberculosis (TB), sponsored by Aeras Global Vaccine Foundation. Started Aug 2013; status: completed.
02
Drugs
AERAS-456
03
Conditions
Tuberculosis (TB)
Beyond the preview
Go deeper on NCT01865487.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01865487.